Prestige Brands Holdings Inc (PBH): Today's Featured Health Care Winner

Prestige Brands Holdings ( PBH) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.5%. By the end of trading, Prestige Brands Holdings rose 15 cents (1.1%) to $13.85 on heavy volume. Throughout the day, two million shares of Prestige Brands Holdings exchanged hands as compared to its average daily volume of 788,300 shares. The stock ranged in a price between $13.62-$14 after having opened the day at $13.92 as compared to the previous trading day's close of $13.70. Other companies within the Health Care sector that increased today were: Rosetta Genomics ( ROSG), up 39.2%, Supernus Pharmaceuticals ( SUPN), up 8.6%, Skystar Bio-Pharmaceutical Company ( SKBI), up 6.8%, and ProPhase Labs ( PRPH), up 6.8%.

Prestige Brands Holdings, Inc., together with its subsidiaries, engages in marketing, selling, and distributing over-the-counter healthcare and household cleaning products primarily in North America. Prestige Brands Holdings has a market cap of $691.4 million and is part of the drugs industry. The company has a P/E ratio of 15.9, above the average drugs industry P/E ratio of 15.8 and below the S&P 500 P/E ratio of 17.7. Shares are up 21.6% year to date as of the close of trading on Thursday. Currently there is one analyst that rates Prestige Brands Holdings a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates Prestige Brands Holdings as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, impressive record of earnings per share growth and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, CEL-SCI Corporation ( CVM), down 18.4%, Savient Pharmaceuticals ( SVNT), down 13.4%, Stereotaxis ( STXS), down 13.1%, and AspenBio Pharma ( APPY), down 12.5%, were all losers within the health care sector with Biogen Idec ( BIIB) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).